Evidence map›Paper›PMID 39846634›Full record

ArticleProteomes2025

Novel Integration of Spatial and Single-Cell Omics Data Sets Enables Deeper Insights into IPF Pathogenesis.

Fei Wang, Liang Jin, Xue Wang, Baoliang Cui, Yingli Yang, Lori Duggan, Annette Schwartz Sterman, Sarah M Lloyd, Lisa A Hazelwood, Neha Chaudhary and 4 more

Abstract read
In one paragraph

Article in Proteomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Fei WangResearch & Development, AbbVie Bioresearch Center, Worcester, MA 01605, USA.ORCID 0000-0002-7969-904X
Liang JinResearch & Development, AbbVie Bioresearch Center, Worcester, MA 01605, USA.ORCID 0000-0002-8659-0536
Xue WangResearch & Development, AbbVie, South San Francisco, CA 94080, USA.ORCID 0000-0002-5267-6083
Baoliang CuiResearch & Development, AbbVie Bioresearch Center, Worcester, MA 01605, USA.
Yingli YangResearch & Development, AbbVie Bioresearch Center, Worcester, MA 01605, USA.
Lori DugganResearch & Development, AbbVie Bioresearch Center, Worcester, MA 01605, USA.
Annette Schwartz StermanResearch & Development, AbbVie Bioresearch Center, Worcester, MA 01605, USA.
Sarah M LloydResearch & Development, AbbVie, North Chicago, IL 60064, USA.ORCID 0000-0001-6197-1482
Lisa A HazelwoodResearch & Development, AbbVie, North Chicago, IL 60064, USA.
Neha ChaudharyResearch & Development, AbbVie Cambridge Research Center, Cambridge, MA 02139, USA.
Bhupinder BawaResearch & Development, AbbVie, North Chicago, IL 60064, USA.
Lucy A PhillipsResearch & Development, AbbVie Bioresearch Center, Worcester, MA 01605, USA.
Yupeng HeResearch & Development, AbbVie, North Chicago, IL 60064, USA.
Yu TianResearch & Development, AbbVie Bioresearch Center, Worcester, MA 01605, USA.ORCID 0000-0003-3754-5875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by repetitive alveolar injuries with excessive deposition of extracellular matrix (ECM) proteins. A crucial need in understanding IPF pathogenesis is identifying cell types associated with histopathological regions, particularly local fibrosis centers known as fibroblast foci. To address this, we integrated published spatial transcriptomics and single-cell RNA sequencing (scRNA-seq) transcriptomics and adopted the Query method and the Overlap method to determine cell type enrichments in histopathological regions. Distinct fibroblast cell types are highly associated with fibroblast foci, and transitional alveolar type 2 and aberrant KRT5-/KRT17+ (KRT: keratin) epithelial cells are associated with morphologically normal alveoli in human IPF lungs. Furthermore, we employed laser capture microdissection-directed mass spectrometry to profile proteins. By comparing with another published similar dataset, common differentially expressed proteins and enriched pathways related to ECM structure organization and collagen processing were identified in fibroblast foci. Importantly, cell type enrichment results from innovative spatial proteomics and scRNA-seq data integration accord with those from spatial transcriptomics and scRNA-seq data integration, supporting the capability and versatility of the entire approach. In summary, we integrated spatial multi-omics with scRNA-seq data to identify disease-associated cell types and potential targets for novel therapies in IPF intervention. The approach can be further applied to other disease areas characterized by spatial heterogeneity.

Indexed as

cell typegene signatureIdiopathic pulmonary fibrosislaser capture microdissectionmass spectrometrymulti-omics integrationprotein signaturescRNA-seqspatial proteomicsspatial transcriptomics

Identifiers

PMID39846634
PMCPMC11755616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.